
PEGS Boston Summit
Date: May 12-16, 2025
Location: Boston, MA
Booth #: 508
JOIN US!
Visit us at booth #508 to connect with an expert and discover Catalent’s latest technology advancements in cell line development, process development, and drug substance manufacturing, from the clinical phase to commercial scale. We are excited to meet with you and demonstrate our comprehensive biologics solutions, showcasing how Catalent can expedite your therapies’ journey to patients.
Don’t miss us in the ‘Difficult to Express Proteins’ Track on Monday, May 12th. Catalent expert Rachel Kravitz will deliver a case study highlighting our cell line development technology and its flexibility to deliver complex molecules.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Monday, May 12, 2025 at 2:50pm
GPEx® Lightning Technology: Overcoming Challenges to Deliver Difficult to Express Proteins
Presented by: Rachel Kravitz, PhD, Principal Scientist R&D Mammalian Cell Biology, Catalent
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) whose mission is to develop, manufacture, and supply products that help people live better and healthier lives. Catalent is dedicated to delivering unparalleled service to pharma, biotech, and consumer health customers, supporting product development, launch, and full life-cycle supply. With time-tested experience in development sciences, delivery technologies, and multi-modality manufacturing, Catalent supports the acceleration of development programs and the launch of more than a hundred new products every year. Powered by thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. www.catalent.com.